VITASPRING BIOMEDICAL CO. LTD.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $0
- Net Income/Loss (FY2025)
- -$415.4K
- Total Assets (FY2025)
- $14.7K
- Total Equity (FY2025)
- -$4.4M
- Cash Flows from Operating Activities (FY2025)
- -$2.7K
Source: VITASPRING BIOMEDICAL CO. LTD. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
